Towards defining the genetic framework for clinical response to treatment with BYL719, a PI3Kalpha-specific inhibitor Meeting Abstract
| Authors: | Rodon, J.; Juric, D.; Gonzalez-Angulo, A. M.; Bendell, J.; Berlin, J.; Bootle, D.; Gravelin, K.; Huang, A.; Derti, A.; Lehár, J.; Wurthner, J.; Boehm, M.; Van Allen, E.; Wagle, N.; Garraway, L. A.; Yelensky, R.; Stephens, P. J.; Miller, V. A.; Schlegel, R.; Quadt, C.; Baselga, J. |
| Abstract Title: | Towards defining the genetic framework for clinical response to treatment with BYL719, a PI3Kalpha-specific inhibitor |
| Meeting Title: | 104th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 8 Suppl. |
| Meeting Dates: | 2013 Apr 6-10 |
| Meeting Location: | Washington, DC |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-04-15 |
| Language: | English |
| ACCESSION: | WOS:000331220601313 |
| DOI: | 10.1158/1538-7445.am2013-lb-65 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LB-65 -- 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 06-10, 2013 -- Washington, DC -- 1 -- Source: Wos |
